Matthew Thornton Health Plan (MTHP) offered two separate smoking cessation programs within the HMO setting. The two programs, telephone intervention with self-help materials and group counseling/education sessions, were evaluated over a 12-month period: both programs allowed members (n = 226) the option of choosing nicotine replacement therapy (NRT). As an incentive, MTHP reimbursed members who were successful quitters at 6 months for the NRT or offered them a $50 savings bond. At 12 months, cessation rates for both groups were at or above 30% except among patients participating in group counseling/education and not receiving NRT where quit rates were about 20%. Though not a controlled research project, results suggest that active HMO intervention in smoking cessation can be successful. In these programs, the combination of behavioral support and a reimbursement plan were associated with high quit rates.

HMO practice / HMO Group

Report of two smoking cessation programs: telephone intervention and group sessions.

Author: Owens Sk ; Malone Nt ; Fleszar Gj ; Joslin Ka

HMO practice

Medicine, society, and the hour of technology. Where are we? Where are we going?

Article

Author: Squires, J W

100 Deals associated with Matthew Thornton Health Plan, Inc.

100 Translational Medicine associated with Matthew Thornton Health Plan, Inc.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 09 Dec 2025

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Matthew Thornton Health Plan, Inc.

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 09 Dec 2025

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing